Literature DB >> 533394

Digoxin removal from a patient with renal failure by hemoperfusion with Amberlite XAD-4 resin.

W Hoy, T P Gibson, T Biddle.   

Abstract

A digitoxic patient with severe renal failure underwent two hemoperfusion treatments with Amberlite XAD-4 resin. Digoxin clearances calculated from plasma flow rates and plasma digoxin concentrations, as well as from the amount of digoxin eluted from the used columns, were superior to those previously described for peritoneal dialysis, hemodialysis and charcoal hemoperfusion. There was a temporary improvement in the patient's life-threatening digitoxic cardiac rhythm with the first hemoperfusion, and a permanent improvement after the second hemoperfusion. It is submitted that hemoperfusion with this resin may significantly lessen manifestations of digoxin poisoning and may hasten digoxin elimination in digitoxic patients with renal failure.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 533394     DOI: 10.1111/j.1525-1594.1979.tb01023.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  1 in total

1.  Endogenous ouabain and cardiomyopathy in dialysis patients.

Authors:  P Stella; P Manunta; F Mallamaci; M Melandri; D Spotti; G Tripepi; J M Hamlyn; L S Malatino; G Bianchi; C Zoccali
Journal:  J Intern Med       Date:  2007-12-07       Impact factor: 8.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.